http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120109824-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4706 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2011-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae57bbe106063d2905fc8fec301ff75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b254b590df0b70bdb76cd0dd1e49cd7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d05c48eb009b1e8764690c119e6980 |
| publicationDate | 2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120109824-A |
| titleOfInvention | Screening method of cancer therapeutic agent using PAHF and its binding partner interaction |
| abstract | The present invention is to contact PAUF with (Pancreatic Adenocarcinoma Up-regulated Factor) and GLRX3, SNAPIN or UBL4A as its binding partner, and the test substance inhibits the binding of GLRX3, SNAPIN or UBL4A as PAUF and its binding partner. The present invention relates to a method for screening a cancer therapeutic agent which is judged as a cancer therapeutic agent by analyzing whether the test substance inhibits the binding, and a pharmaceutical composition for inhibiting and treating cancer including the test substance as an active ingredient. The pharmaceutical composition of the present invention comprising a binding inhibitor between PAUF and binding partner as an effective ingredient can effectively treat various cancers (especially pancreatic cancer) by effectively blocking signaling of PAUF related to the onset of cancer. |
| priorityDate | 2011-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 668.